# Lophius Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lophius-biosciences

- Industry: Biotechnology
- Headquarters: Regensburg, Germany
- Website: www.lophius.com
- Total disclosed funding: $2.8M
- Latest round: Series B (May 17, 2010)
- Investors on record: 3

## About

Lophius Biosciences GmbH specializes in developing innovative diagnostic solutions for infectious diseases and personalized medicine, aiming to improve patient outcomes through advanced testing methodologies.Founded in 2002 in Regensburg, Germany, Lophius Biosciences GmbH focuses on diagnostics in healthcare. The company has successfully completed 9 deals, with the latest funding round in March 2017 where they raised EUR 2.2 million, led by VRD with participation from Bayern Kapital and Wolf Biotech GmbH. The founder, Nadja Prang, has a background that contributes to the company's innovative edge.Lophius Biosciences GmbH offers advanced diagnostic solutions, specifically targeting infectious diseases through proprietary testing methodologies. Their products focus on enhancing the accuracy of diagnostic results to aid in personalized medicine approaches, thereby catering to healthcare institutions and laboratories looking to implement better testing solutions.In the most recent fiscal year of 2019, Lophius Biosciences GmbH reported a revenue of EUR 226,958.60, alongside an EBITDA of EUR -2,619,637.20, reflecting their investments in product development and market expansion.Moving forward, Lophius Biosciences GmbH plans to leverage the EUR 2.2 million raised in March 2017 to support the launch of new diagnostic products aimed at infectious diseases, with rollouts expected in the upcoming years. The company is also looking to expand its presence in untapped markets across North America and Asia by 2025, enhancing the accessibility of its innovative diagnostic solutions in these regions.

## Funding rounds

- Series B, May 17, 2010, $2M — S-Refit, High-Tech Gruenderfonds, Bayern Kapital
- Seed, Oct 2, 2008, $0.8M — High-Tech Gruenderfonds, Bayern Kapital

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed, Series B
- Bayern Kapital (https://capitalatlas.ai/funds/bayern-kapital) — Seed, Series B
- S-Refit (https://capitalatlas.ai/funds/s-refit) — Series B